Immuron (IMRN) Payables (2016 - 2025)
Immuron (IMRN) posted quarterly Payables of $15294.3 for Q3 2025, down 28.39% year-on-year from $21358.5 in Q3 2024, and down 98.58% on a QoQ basis from $1.1 million in Q2 2025.
Immuron (IMRN) Payables (2016 - 2025) Analysis & Trends
Immuron (IMRN) has reported Payables for 10 consecutive years, with $15294.3 the latest figure, recorded in Q3 2025.
- Quarterly Payables fell 28.39% year-over-year to $15294.3 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $15294.3 (down 28.39% YoY) and the FY2025 annual result came in at $15294.3, down 28.39% from the prior year.
- Payables eased to $15294.3 in Q3 2025 per IMRN's latest filing, from $1.1 million in the prior quarter.
- Over the last five years, Payables for IMRN reached as high as $1.5 million in Q2 2024 and fell as low as $11758.3 in Q4 2023.
- A 5-year average of $626700.4 and a median of $819851.3 in 2022 frame the typical range for Payables.
- Annual changes were most pronounced in 2021 — Payables jumped 22389.26% — and 2023, when it sank 98.57%.
- Year by year, Payables stood at $535667.2 in 2021, then jumped by 53.05% to $819851.3 in 2022, then plunged by 98.57% to $11758.3 in 2023, then soared by 7633.56% to $909337.0 in 2024, then sank by 98.32% to $15294.3 in 2025.
- According to Business Quant data, Payables over the past three periods registered $15294.3, $1.1 million, and $909337.0 for Q3 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Immuron | 270.20 Mn | 258.54 Mn | - | 15,294.34 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | 15,294.34 |
| Jun 30, 2025 | 1.08 Mn |
| Dec 31, 2024 | 909,337.01 |
| Sep 9, 2024 | 21,358.52 |
| Jun 30, 2024 | 1.51 Mn |
| Dec 31, 2023 | 11,758.32 |
| Sep 28, 2023 | 842,362.90 |
| Aug 30, 2023 | 11,927.69 |
| Jun 30, 2023 | 842,362.90 |
| Dec 31, 2022 | 819,851.28 |
| Aug 31, 2022 | 819,851.28 |
| Jun 30, 2022 | 819,851.28 |
| Dec 31, 2021 | 535,667.18 |
| Jun 30, 2021 | 535,667.18 |
| Dec 31, 2020 | 2,381.88 |
| Sep 1, 2020 | 384,397.00 |
| Jun 30, 2020 | 271,470.65 |
| Dec 31, 2019 | 101,963.97 |
| Jun 30, 2019 | 1.09 Mn |
| Dec 31, 2018 | 689,326.00 |